Janssen is foreign company of the year in Denmark

The American Chamber of Commerce in Denmark, Amcham, on Thursday celebrated the pharmaceutical company Janssen for its engagement in the Danish healtcare sector.

Photo: Amcham / PR

At an arrangement on Thursday, the pharmaceutical company Janssen was named the foreign company of the year in Denmark by Amcham, the American Chamber of Commerce in Denmark, which annually awards the title in a collaboration with Copenhagen Capacity.

Janssen, which is the pharmaceutical branch of the giant Johnson and Johnson, is recognized with the award for its engagements in the Danish healthcare system – for instance, the company has partnered with Rigshospitalet to work on clinical studies of cellular immunotherapy for multiple myeloma treatment.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs